Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Oct 01, 2020 (The Expresswire) --
Global Primary Sclerosing Cholangitis Market Report offers an in-depth analysis of the market size (revenue), market share,...
Schonfeld Strategic Advisors LLC Takes Position in Cerus Co. (NASDAQ:CERS)
07:02am, Tuesday, 29'th Sep 2020
Schonfeld Strategic Advisors LLC bought a new position in shares of Cerus Co. (NASDAQ:CERS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 26,704 shares
Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting
12:00am, Monday, 28'th Sep 2020
Cerus Corporation (Nasdaq:CERS) announced today its lineup of abstract presentations at the AABB 2020 Virtual Annual Meeting, which will take place on
215,592 Shares in Cerus Co. (NASDAQ:CERS) Bought by Marshall Wace North America L.P.
06:58am, Thursday, 10'th Sep 2020
Marshall Wace North America L.P. bought a new position in Cerus Co. (NASDAQ:CERS) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 215,592 shares of the
Q3 2020 EPS Estimates for Intercept Pharmaceuticals Inc Boosted by Analyst (NASDAQ:ICPT)
01:18am, Friday, 28'th Aug 2020
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) – Investment analysts at Wedbush raised their Q3 2020 EPS estimates for shares of Intercept Pharmaceuticals in a research report issued to clients and inv
Research Analysts Issue Forecasts for Intercept Pharmaceuticals Inc’s Q3 2020 Earnings (NASDAQ:ICPT)
06:44am, Thursday, 27'th Aug 2020
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) – Analysts at Piper Sandler reduced their Q3 2020 earnings estimates for shares of Intercept Pharmaceuticals in a research note issued to investors on Mon
These Plasma Stocks Are Surging After FDA's Convalescent EUA
12:00am, Monday, 24'th Aug 2020
Health care stocks levered to blood collection and sampling, and plasma therapy biopharma companies are getting a big boost Monday after the FDA issued emergency use authorization...
Traders can’t mares this Stock: 22nd Century Group, Inc. (XXII), Cerus Corporation (CERS) - Stocks Equity
11:06pm, Sunday, 23'rd Aug 2020
22nd Century Group, Inc. (AMEX:XXII) with the stream of 0.21% also noticed, India Cerus Corporation (NASDAQ:CERS) encountered a rapid change of 0.00%. 22nd Century Group, Inc. (AMEX:XXII) closed at $0
Did Hedge Funds Make The Right Call On Cerus Corporation (CERS) ?
01:26pm, Wednesday, 12'th Aug 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Have Insiders Been Buying Cerus Corporation (NASDAQ:CERS) Shares This Year?
10:48am, Tuesday, 11'th Aug 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch
12:30pm, Friday, 07'th Aug 2020
Cerus Corporation (Nasdaq:CERS) announced today that INTERCEPT Blood Systems disposable kit shipments have surpassed 7.5 million treatable platelet and plasma doses globally since commercial launch.
Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch
12:00am, Friday, 07'th Aug 2020
Cerus Corporation (Nasdaq:CERS) announced today that INTERCEPT Blood Systems disposable kit shipments have surpassed 7.5 million treatable platelet an
Cerus Corporation (CERS) Q2 2020 Earnings Call Transcript | The Motley Fool
06:01am, Wednesday, 05'th Aug 2020
CERS earnings call for the period ending June 30, 2020.
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates
09:15pm, Tuesday, 04'th Aug 2020
Cerus (CERS) delivered earnings and revenue surprises of 10.00% and 0.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Cerus Corporation Announces Record Second Quarter 2020 Results
08:02pm, Tuesday, 04'th Aug 2020
Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2020.
